Preliminary data on the risk of blood clots with the Ortho Evra contraceptive patch warrant further analysis but no immediate regulatory action, the FDA said today.Ortho Women’s Health, a unit of ...

The U.S. Food and Drug Administration approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that ...

FORT WORTH, Texas, Sept. 21 /PRNewswire/ -- The U.S. Food and Drug Administration's announcement that additional warnings have been added to the label for Johnson & Johnson's (NYSE: JNJ) Ortho Evra ...

Johnson & Johnson has settled lawsuits with about 30 women who claim they developed blood clots after using the company’s Ortho Evra birth control patch, said a lawyer who negotiated the confidential ...

WASHINGTON (Reuters) - A U.S. advocacy group is urging the Food and Drug Administration to pull Johnson & Johnson's birth control patch from the market after studies found an increased risk of ...

NEW YORK, July 13, 2006 (PRIMEZONE) -- Parker & Waichman, LLP (www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc.

WASHINGTON -- American women may soon buy the world's first birth control in a skin patch. The Food and Drug Administration approved Ortho-Evra on Tuesday, a patch that prevents pregnancy by emitting ...

May 9 -- Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Pull Ortho-Evra Birth-Control Patch From Market: Public Citizen The Ortho-Evra birth ...

An overseas Internet site is shipping counterfeit versions of a popular Johnson & Johnson birth control patch, versions that won’t provide any protection against pregnancy, U.S. health officials ...

WASHINGTON — U.S. health officials approved the sale of the world’s first contraceptive patch Tuesday, giving women an option considered as safe and effective as the pill but easier for some to use.